Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | May 16, 2014 |
| Target | CFR Pharmaceuticals S.A. |
| Sector | Life Science |
| Buyer(s) | Abbott |
| Deal Type | Add-on Acquisition |
| Deal Value | 2.9B USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1888 |
| Sector | Medical Products |
| Employees | 114,000 |
| Revenue | 42.0B USD (2024) |
Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.
| Deal Context for Buyer | # |
|---|---|
| Overall | 25 of 36 |
| Sector: Life Science | 10 of 12 |
| Type: Add-on Acquisition | 25 of 36 |
| Country: Chile | 1 of 1 |
| Year: 2014 | 1 of 3 |
| Size (of disclosed) | 9 of 29 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-08-19 |
OptiMedica
Santa Clara, California, United States OptiMedica Corp. is an ophthalmic device company. |
Buy | $250M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-06-23 |
Veropharm
Moscow, Russia Veropharm is a Russian pharmaceutical producer known in Russia and abroad as one of Russia’s major manufacturers of generic drugs that are identical to their brand name counterparts, oncological medications, and medical adhesive bandages. |
Buy | $305M |
